Pfizer, Inc. (PFE)

44.06 -0.63%
Feb 04 close; Powered by Koyfin
Pros
Revenue growth higher than the industry and sector averages
Company’s profitability is improving
Forward dividend yield higher than the industry and sector averages
Forward P/B ratio low relative to industry peers
Forward P/S ratio low relative to industry peers
Forward PEG ratio low relative to industry peers
Buy analyst rating
Average analyst stock price above current stock price
Cons
High short interest

Pros

  1. PFE quarterly revenue growth was 46.80%, higher than the industry and sector average revenue growth (12.60% and 5.67%, respectively). See PFE revenue growth chart.
  2. PFE profitability is improving. The YoY profit margin change was 26.89 percentage points. See PFE profitability chart.
  3. PFE forward dividend yield is 3.51%, higher than the industry (2.18%) and sector (0.20%) forward dividend yields. See PFE forward dividend chart.
  4. PFE Price/Book ratio is 3.86, which is low compared to its industry peers’ P/B ratios. See PFE forward Price/Book ratio chart.
  5. PFE Price/Sales ratio is 2.43, which is low compared to its industry peers’ P/S ratios. See PFE forward Price/Sales ratio chart.
  6. PFE PEG ratio (P/E adjusted for growth) is 0.01, which is low compared to its industry peers’ PEG ratios. See PFE PEG chart.
  7. PFE average analyst rating is Buy. See PFE analyst rating chart.
  8. PFE average analyst price target ($55.88) is above its current price ($43.97). See PFE price target chart.

Cons

  1. PFE short interest (days to cover the shorts) ratio is 3.19. The stock garners more short interest than the average industry, sector or S&P 500 stock. See PFE short interest ratio chart.